| ²é¿´: 274 | »Ø¸´: 3 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
·ÒëÒ»¾ä»°
|
|||
|
Campillos et al. (2008) was the use of similarities in the sideeffects of known drugs to predict new drug-target interactions, some of which were verified by in vitro binding assays. The limitation of this approach is that it only applies to known side-effects of known drugs, thus limiting the ability of the method to perform high-throughput screening of potential interactions between new molecules and proteins. |
» ²ÂÄãϲ»¶
368»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0703»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
µ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ13È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
»úе¹¤³Ì313·ÖÕÒ¹¤¿Æµ÷¼Á
ÒѾÓÐ3È˻ظ´
¿¼Ñе÷¼Á-²ÄÁÏÀà-284
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ÏôóÉúÎïѧ332Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ºÓ±±´óѧ·ÖÎö»¯Ñ§ÕÐÊÕ¶àÃûµ÷¼Á¿¼Éú
+5/619
½Î÷ʦ´ó»¯Ñ§¹¤³ÌѧԺµ÷¼Á½ñÍí0µã¿ª·Å£¡ ȱ¶î100¸ö£¬Ëٳ壡
+1/88
Î÷°²Ê¯ÓÍ´óѧÐÂÄÜԴѧԺ½ÓÊÕ²ÄÁÏÀà¡¢ÄÜÔ´¶¯Á¦Àà¡¢»úеÀà¡¢¼ÆËã»úÀàµÈרҵר˶µ÷¼ÁÉú£¡
+1/87
º¼ÖÝʦ·¶´óѧÕÅÁú¿ÎÌâ×éÕÐ³ÏÆ¸ÓлúºÏ³É£¬¹âµç´ß»¯£¬ÀíÂÛ¼ÆËãÓëÈ˹¤ÖÇÄÜ»¯Ñ§·½Ïò²©Ê¿ºó
+1/87
Õã½Àí¹¤´óѧ½¯ÖÙÇì ÎïÀí/ÐÂÄÜÔ´/²ÄÁÏ ÕÐ9Ãû
+2/48
¹ã¶«Ê¯ÓÍ»¯¹¤Ñ§ÔºÁõʫӽ½ÌÊÚÍŶӻ¯Ñ§»¯¹¤¡¢²ÄÁÏ¿ÆÑ§µÈ·½ÏòÉÐÓе÷¼ÁÃû¶î
+1/43
ÉÇÍ·´óÑо¿Éúµ÷¼ÁÕÐÉú
+1/31
±±¾©Àí¹¤´óѧ£¨Ö麣£©ÕÐÊÕ2026¼¶¿¼ºËÖÆ²©Ê¿
+1/21
Õã½Å©ÁÖ´óѧ ÁÖÒµÓëÉúÎï¼¼ÊõѧԺ ÉúÎïѧ(ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ) µÚÒ»ÂÖµ÷¼ÁÉúÕÐÉú
+1/13
±±»ª´óѧÁÖ²ú»¯Ñ§¼Ó¹¤¹¤³Ìѧ˶ºÍ²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼ÁÕÐÉú
+1/11
ºÓÄÏÀí¹¤´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÕÐÉú²ÄÁÏ¡¢»¯¹¤µÈÏà¹Ø×¨Òµµ÷¼ÁÑо¿Éú
+1/10
½ÌÓý²¿³¤½Ñ§Õߺʹ´ÐÂÍŶӷ¢Õ¹¼Æ»®¡±ÈëÑ¡ÍŶÓÕÐÊÕ ²ÄÁÏÓ뻯¹¤Ë¶Ê¿Ñо¿Éú£¨¹¤¿Æ£©
+1/9
ÖпÆÔº¶«Ý¸²ÄÁÏËù¶þά²ÄÁÏÓëÖÇÄÜÆ÷¼þ·½ÏòÕÐÆ¸
+1/8
ÕҺù¤×÷À´ÎÒÕâ-¹ã¶«Î¨Ò»Ê¯»¯ÔºÐ£¡ª¡ª×ÊÔ´Óë»·¾³×¨Ë¶ÕÐÉú
+1/5
½ÜÇà/³¤½ÍŶÓÕÐÊÕ˶ʿµ÷¼Á
+1/5
Íõ½ð·ï½ÌÊÚÍŶÓ
+1/5
2026ÄêÖÐÄÏÃñ×å´óѧ»¯Ñ§Óë²ÄÁÏ¿ÆÑ§Ñ§Ôºµ÷¼Á¹«¸æ
+5/5
ÆëÆë¹þ¶û´óѧÀîÀò¿ÎÌâ×é³ÏÕÐ2026¼¶¿¼Ñе÷¼ÁÉú£¨Ñ§Ë¶ºÍר˶£©
+1/5
ÕÐÊÕÓ«¹â̽Õë/ÓлúºÏ³É/ÉúÎïѧ²©Ê¿Éú
+1/5
̨ÖÝѧԺ½ÓÊÕ»¯Ñ§¡¢»¯¹¤Óë²ÄÁÏ·½Ïòµ÷¼Á
+1/3
8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12916.1
- Ìû×Ó: 4183
- ÔÚÏß: 357.8Сʱ
- ³æºÅ: 1184404
3Â¥2011-03-04 09:38:04
8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12916.1
- Ìû×Ó: 4183
- ÔÚÏß: 357.8Сʱ
- ³æºÅ: 1184404
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
pku123(½ð±Ò+1, ·ÒëEPI+1): 2011-03-04 09:37:38
pku123(½ð±Ò+1): 2011-03-05 07:32:19
ringzhu(½ð±Ò+16): ²»½âÊÍ~~ 2011-03-15 10:23:03
pku123(½ð±Ò+1, ·ÒëEPI+1): 2011-03-04 09:37:38
pku123(½ð±Ò+1): 2011-03-05 07:32:19
ringzhu(½ð±Ò+16): ²»½âÊÍ~~ 2011-03-15 10:23:03
|
Campillos et al. (2008) was the use of similarities in the side effects of known drugs to predict new drug-target interactions, some of which were verified by in vitro binding assays. The limitation of this approach is that it only applies to known side-effects of known drugs, thus limiting the ability of the method to perform high-throughput screening of potential interactions between new molecules and proteins. Campillos µÈ(2008)ÓÃÒ»Ö»Ò©ÎïµÄ¸±×÷ÓõÄÏàËÆÐÔÔ¤²âÐÂÒ©ºÍ°Ð±ê¼äµÄÏ໥×÷Óã¬ÆäÖÐһЩÏ໥×÷ÓÃÓÉÌåÄÚ½áºÏʹÓÃÈ·Ö¤¡£ÕâÖÖ·½·¨µÄ¾ÖÏÞÊÇËüÖ»Ó¦ÓÃÁËÒÑÖªÒ©ÎïµÄÒÑÖª¸±×÷Óã¬Òò´ËÏÞÖÆÁËÆäÔÚзÖ×Ӻ͵°°×ÖÊÖ®¼äDZÔÚÏ໥×÷ÓõĸßͨÁ¿É¸Ñ¡ÖеÄÓ¦Óᣠ|
2Â¥2011-03-04 09:37:04
8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12916.1
- Ìû×Ó: 4183
- ÔÚÏß: 357.8Сʱ
- ³æºÅ: 1184404
4Â¥2011-03-04 11:12:58














»Ø¸´´ËÂ¥